Physician profile
Ashley E Hisel
NPI 1134431497
$760.42
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $620 · 2020: $140.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $144.65 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $63.22 | 2019-2020 | |
| Glaxosmithkline, LLC. | $48.15 | 2019 | |
| Supernus Pharmaceuticals, INC. | $45.90 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $41.66 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $38.09 | 2019-2020 | |
| Grifols USA, LLC | $34.52 | 2019 | |
| Pfizer INC. | $29.46 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $29.45 | 2019-2020 | |
| Amgen INC. | $28.79 | 2019 | |
| Philips North America LLC | $27.43 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.29 | 2019 | |
| Novo Nordisk INC | $26.20 | 2019 | |
| Shire North American Group INC | $25.39 | 2019 | |
| Merck Sharp & Dohme LLC | $24.54 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $16.77 | 2019 | |
| Genentech USA, INC. | $16.53 | 2019 | |
| Mallinckrodt Enterprises LLC | $14.98 | 2019 | |
| Smith+Nephew, INC. | $14.96 | 2019 | |
| Mylan Specialty L.P. | $14.24 | 2020 | |
| Csl Behring | $14.00 | 2019 | |
| United Therapeutics Corporation | $12.53 | 2020 | |
| Lilly USA, LLC | $11.37 | 2019 | |
| Kci USA, INC. | $11.30 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Hisel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.